Indication: 1. Used to treat viral or fungal infections that are difficult to control with certain antibiotics (such as herpes zoster, epidemic encephalitis B, Candida albicans infection, viral myocarditis, etc.). 2. Used as an adjuvant therapy for malignant tumors (mainly used for lung cancer, nasopharyngeal carcinoma, breast cancer, osteosarcoma, etc.). 3. Used for immunodeficiency diseases (such as eczema, thrombocytopenia, multiple infection syndrome and chronic skin and mucosal fungal diseases), and also has a certain therapeutic effect on autoimmune diseases.

Indication: 1. Used to treat viral or fungal infections that are difficult to control with certain antibiotics (such as herpes zoster, epidemic encephalitis B, Candida albicans infection, viral myocarditis, etc.). 2. Used as an adjuvant therapy for malignant tumors (mainly used for lung cancer, nasopharyngeal carcinoma, breast cancer, osteosarcoma, etc.). 3. Used for immunodeficiency diseases (such as eczema, thrombocytopenia, multiple infection syndrome and chronic skin and mucosal fungal diseases), and also has a certain therapeutic effect on autoimmune diseases.

Indication: 1. Used to treat viral or fungal infections that are difficult to control with certain antibiotics (such as herpes zoster, epidemic encephalitis B, Candida albicans infection, viral myocarditis, etc.). 2. Used as an adjuvant therapy for malignant tumors (mainly used for lung cancer, nasopharyngeal carcinoma, breast cancer, osteosarcoma, etc.). 3. Used for immunodeficiency diseases (such as eczema, thrombocytopenia, multiple infection syndrome and chronic skin and mucosal fungal diseases), and also has a certain therapeutic effect on autoimmune diseases.

Indication: 1. Used to treat viral or fungal infections that are difficult to control with certain antibiotics (such as herpes zoster, epidemic encephalitis B, Candida albicans infection, viral myocarditis, etc.). 2. Used as an adjuvant therapy for malignant tumors (mainly used for lung cancer, nasopharyngeal carcinoma, breast cancer, osteosarcoma, etc.). 3. Used for immunodeficiency diseases (such as eczema, thrombocytopenia, multiple infection syndrome and chronic skin and mucosal fungal diseases), and also has a certain therapeutic effect on autoimmune diseases.

Indication: Used for the treatment of breast cancer, lung cancer, liver cancer, leukemia, rectal cancer, colon cancer, bladder cancer, gastric cancer, kidney cancer, pancreatic cancer, osteosarcoma, malignant lymphoma, brain tumors, etc.

Indication: It is the first-line drug for the treatment of various solid tumors. Combination with VP-16 (EP regimen) is the first-line treatment for SCLC or NSCLC. Combination with MMC, IFO (IMP regimen), or NVB is the commonly used regimen for the treatment of NSCLC. Combination chemotherapy based on DDP is also the main treatment for advanced ovarian cancer, osteosarcoma and neuroblastoma. Combination with ADM, CTX, etc. is effective for squamous cell carcinoma and transitional cell carcinoma in multiple sites, such as head and neck, cervix, esophagus and urinary system tumors. PVB (DDP, VLB, BLM) can treat most stage IV non-spermatogonia testicular cancers, with a remission rate of 50℅ to 80℅. In addition, this product is a radiotherapy sensitizer. It is currently widely used in foreign countries for local radiotherapy of stage IV inoperable NSCLC, which can improve efficacy and survival.

Indication: This product is a first-line drug for the treatment of various solid tumors. Combination with VP-16 (EP regimen) is a first-line regimen for the treatment of SCLC or NSCLC. Combination with MMC, IFO (IMP regimen), or NVB is a commonly used regimen for the treatment of NSCLC. Combination chemotherapy based on DDP is also the main treatment for advanced ovarian cancer, osteosarcoma and neuroblastoma. Combination with ADM, CTX, etc. is effective for squamous cell carcinoma and transitional cell carcinoma in multiple sites, such as head and neck, cervix, esophagus and urinary system tumors. "PVB" (DDP, VLB, BLM) can treat most stage IV non-spermatogonia testicular cancers with a remission rate of 50% to 80%. In addition, this product is a radiotherapy sensitizer. It is currently widely used in foreign countries for local radiotherapy of stage IV inoperable NSCLC, which can improve efficacy and survival.

Indication: It is the first-line drug for the treatment of various solid tumors. Combination with VP-16 (EP regimen) is the first-line treatment for SCLC or NSCLC. Combination with MMC, IFO (IMP regimen), or NVB is the commonly used regimen for the treatment of NSCLC. Combination chemotherapy based on DDP is also the main treatment for advanced ovarian cancer, osteosarcoma and neuroblastoma. Combination with ADM, CTX, etc. is effective for squamous cell carcinoma and transitional cell carcinoma in multiple sites, such as head and neck, cervical, esophageal and urinary system tumors.

Indication: It is the first-line drug for the treatment of various solid tumors. Combination with VP-16 (EP regimen) is the first-line treatment for SCLC or NSCLC. Combination with MMC, IFO (IMP regimen), or NVB is the commonly used regimen for the treatment of NSCLC. Combination chemotherapy based on DDP is also the main treatment for advanced ovarian cancer, osteosarcoma and neuroblastoma. Combination with ADM, CTX, etc. is effective for squamous cell carcinoma and transitional cell carcinoma in multiple sites, such as head and neck, cervical, esophageal and urinary system tumors.

Indication: Suitable for testicular cancer, ovarian cancer, breast cancer, sarcoma, malignant lymphoma and lung cancer, etc.